Establishment of reference values based on influential characteristics of hematopoietic stem cells and immune cell subsets in the bone marrow

Autor: Rebar N. Mohammed, Najmaddin S.H. Khoshnaw, Vian Faeq Mohammed, Dastan O. Hassan, Chra Nawfal Abdullah, Tavan Ismael Mahmood, Huda A. Abbass, Dereen Ahmed, Kani D. Noori, Lanja I. Saeed, Salah Mohammed Salih, Hiwa S. Sidiq, Dlnya Omer Ali, Alan Shwan, Ignazio Majolino, Francesco Ipsevich

Publikováno v: Heliyon, Vol 10, Iss 9, Pp e30888- (2024)

Hematopoietic stem cell transplantation is still a curative treatment for many haematological cancers. Many factors, such as age, sex, ethnic background, smoking status, and body mass index, affect average reference values in different populations. T

Externí odkaz: https://doaj.org/article/84c262e32d1a4e17844046548e61c3fe

THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

Autor: Ignazio Majolino

Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases, Vol 9, Iss 1, Pp e2017031-e2017031 (2017)

We describe the entire process leading to the start-up of an hematopoietic stem cell transplantation center at the Hiwa Cancer Hospital, in the city of Sulaymaniyah, Kurdistan Iraqi Region. This capacity building project was funded by the Italian Age

Externí odkaz: https://doaj.org/article/e261a7c2dbc14166a45cd353f04d6ea1

Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement

Autor: Corrado Girmenia, Claudio Viscoli, Alfonso Piciocchi, Laura Cudillo, Stefano Botti, Antonio Errico, Loredana Sarmati, Fabio Ciceri, Franco Locatelli, Maddalena Giannella, Matteo Bassetti, Carlo Tascini, Letizia Lombardini, Ignazio Majolino, Claudio Farina, Francesco Luzzaro, Gian Maria Rossolini, Alessandro Rambaldi

Publikováno v: Haematologica, Vol 100, Iss 9 (2015)

Externí odkaz: https://doaj.org/article/a2d1692fa56b478092a149cd98631a58

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

Autor: Mohamad Mohty, Myriam Labopin, Reza Tabrizzi, Niklas Theorin, Axel A Fauser, Alessandro Rambaldi, Johan Maertens, Shimon Slavin, Ignazio Majolino, Arnon Nagler, Didier Blaise, Vanderson Rocha

Publikováno v: Haematologica, Vol 93, Iss 2 (2008)

This retrospective study reported the outcome of 97 adult acute lymphoblastic leukemia patients who received a reduced-intensity conditioning allogeneic stem cell transplantation. With a median follow-up of 2.8 years, two year overall-survival, leuke

Externí odkaz: https://doaj.org/article/e51ba6c1e6b64cbb90fe258ae2ce860f

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Autor: Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino

Publikováno v: The Lancet Haematology. 7:e861-e873

Background: The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD) as induction therapy before and consolidation therapy after double autologous h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d247cf6931cb796a2568e2552250ca02
https://doi.org/10.1016/s2352-3026(20)30323-9